Product Information

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1862 per EA under NDC 68462087805. Its NADAC has been published 227 times since Feb 23, 2022.

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB

Bisoprolol Fumarate and Hydrochlorothiazide
$0.1862per EA

Strength

2.5; 6.25 mg/1; mg/1

NDC

68462087805

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215995

On Market Since

1/26/2022

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has been published 227 times since Feb 23, 2022, and over the history we have for it it has declined 43.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1862 per EA
All-time high$0.3901 (May 11, 2022)
All-time low$0.1729 (Nov 20, 2024)
52-week high$0.2138
52-week low$0.1855
Median price$0.2410
Average price$0.2528
Largest weekly change+63.0% (Nov 22, 2023)
Weeks tracked227
Tracking sinceFeb 23, 2022

Price History

1W

0.0%

1M

-1.1%

3M

-4.6%

6M

-7.6%

1Y

-10.6%

3Y

-35.6%

5Y

N/A

All

-43.7%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1862 per EA (NDC 68462087805), effective Jun 24, 2026.

How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB changed over time?

Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has declined 43.7%. It has been tracked across 227 weekly CMS publications since Feb 23, 2022.

What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

Since Feb 23, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has ranged from a low of $0.1729 (Nov 20, 2024) to a high of $0.3901 (May 11, 2022), with a median of $0.2410 per EA.

Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

3 NADAC-published products share the same active ingredient, strength, and dosage form as BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, but none are currently priced below it.

Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?

BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB (NDC 68462087805) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.